Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012

John T. Reilly; Mary Frances Mcmullin; Philip A. Beer; Nauman Butt; Eibhlin Conneally; Andrew S. Duncombe; Anthony R. Green; George Mikhaeel; Marie H. Gilleece; Steven Knapper; Adam J. Mead; Ruben A. Mesa; Mallika Sekhar; Claire N. Harrison

doi:10.1111/bjh.12985

Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012

John T. Reilly, Mary Frances Mcmullin, Philip A. Beer, Nauman Butt, Eibhlin Conneally, Andrew S. Duncombe, Anthony R. Green, George Mikhaeel, Marie H. Gilleece, Steven Knapper, Adam J. Mead, Ruben A. Mesa, Mallika Sekhar, Claire N. Harrison

Research output: Contribution to journal › Letter › peer-review

31 Scopus citations

Original language	English (US)
Pages (from-to)	418-420
Number of pages	3
Journal	British Journal of Haematology
Volume	167
Issue number	3
DOIs	https://doi.org/10.1111/bjh.12985
State	Published - Nov 1 2014
Externally published	Yes

Keywords

CALR
JAK inhibition
Myeloproliferative disease

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/bjh.12985

Cite this

Reilly, J. T., Mcmullin, M. F., Beer, P. A., Butt, N., Conneally, E., Duncombe, A. S., Green, A. R., Mikhaeel, G., Gilleece, M. H., Knapper, S., Mead, A. J., Mesa, R. A., Sekhar, M., & Harrison, C. N. (2014). Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012. British Journal of Haematology, 167(3), 418-420. https://doi.org/10.1111/bjh.12985

Use of JAK inhibitors in the management of myelofibrosis : A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012. / Reilly, John T.; Mcmullin, Mary Frances; Beer, Philip A.; Butt, Nauman; Conneally, Eibhlin; Duncombe, Andrew S.; Green, Anthony R.; Mikhaeel, George; Gilleece, Marie H.; Knapper, Steven; Mead, Adam J.; Mesa, Ruben A.; Sekhar, Mallika; Harrison, Claire N.

In: British Journal of Haematology, Vol. 167, No. 3, 01.11.2014, p. 418-420.

Research output: Contribution to journal › Letter › peer-review

Reilly, JT, Mcmullin, MF, Beer, PA, Butt, N, Conneally, E, Duncombe, AS, Green, AR, Mikhaeel, G, Gilleece, MH, Knapper, S, Mead, AJ, Mesa, RA, Sekhar, M & Harrison, CN 2014, 'Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012', British Journal of Haematology, vol. 167, no. 3, pp. 418-420. https://doi.org/10.1111/bjh.12985

Reilly, John T. ; Mcmullin, Mary Frances ; Beer, Philip A. ; Butt, Nauman ; Conneally, Eibhlin ; Duncombe, Andrew S. ; Green, Anthony R. ; Mikhaeel, George ; Gilleece, Marie H. ; Knapper, Steven ; Mead, Adam J. ; Mesa, Ruben A. ; Sekhar, Mallika ; Harrison, Claire N. / Use of JAK inhibitors in the management of myelofibrosis : A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012. In: British Journal of Haematology. 2014 ; Vol. 167, No. 3. pp. 418-420.

@article{d56a2efdd57241f1a3453fa8b8e935e1,

title = "Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012",

keywords = "CALR, JAK inhibition, Myeloproliferative disease",

author = "Reilly, {John T.} and Mcmullin, {Mary Frances} and Beer, {Philip A.} and Nauman Butt and Eibhlin Conneally and Duncombe, {Andrew S.} and Green, {Anthony R.} and George Mikhaeel and Gilleece, {Marie H.} and Steven Knapper and Mead, {Adam J.} and Mesa, {Ruben A.} and Mallika Sekhar and Harrison, {Claire N.}",

year = "2014",

month = nov,

day = "1",

doi = "10.1111/bjh.12985",

language = "English (US)",

volume = "167",

pages = "418--420",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Use of JAK inhibitors in the management of myelofibrosis

T2 - A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012

AU - Reilly, John T.

AU - Mcmullin, Mary Frances

AU - Beer, Philip A.

AU - Butt, Nauman

AU - Conneally, Eibhlin

AU - Duncombe, Andrew S.

AU - Green, Anthony R.

AU - Mikhaeel, George

AU - Gilleece, Marie H.

AU - Knapper, Steven

AU - Mead, Adam J.

AU - Mesa, Ruben A.

AU - Sekhar, Mallika

AU - Harrison, Claire N.

PY - 2014/11/1

Y1 - 2014/11/1

KW - CALR

KW - JAK inhibition

KW - Myeloproliferative disease

UR - http://www.scopus.com/inward/record.url?scp=84912000790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912000790&partnerID=8YFLogxK

U2 - 10.1111/bjh.12985

DO - 10.1111/bjh.12985

M3 - Letter

C2 - 24961987

AN - SCOPUS:84912000790

VL - 167

SP - 418

EP - 420

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -

Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this